FDA holds public meeting on nanotechnology.
Traynor
Kate
K
D064420:Drug-Related Side Effects and Adverse Reactions; D033161:Government Regulation; D006801:Humans; D049329:Nanostructures / Q000009:adverse effects / Q000592:standards; D036103:Nanotechnology / Q000331:legislation & jurisprudence*; D004364:Pharmaceutical Preparations / Q000592:standards; D013678:Technology, Pharmaceutical / Q000331:legislation & jurisprudence*; D009626:Terminology as Topic; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations